Viscogliosi Brothers Acquisition (VBOCU) Peer Comparison
$10.47
$0.00 (0.00%)As on 28-Jul-2023 09:30EDT
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Edit
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
-- | 5,723 | 3,425 | 812 | 427 |
Revenue ($ Mln) |
-- | 440 | 2,883 | -- | 58 |
Net Profit ($ Mln) |
0.50 | -1,435.01 | -118.30 | -134.20 | -50.70 |
Net Margin (%) |
-- | -325.91 | -4.10 | -- | -88.09 |
RoE (%) |
0.58 | -- | -- | -40.17 | -54.90 |
Price to Earnings |
-- | -- | -- | -- | -- |
Price-To-Book |
-- | -- | 1.35 | -- | 2.89 |
Income Statement ($ Mln)
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 640.31 | 3,083.80 | 32.22 | 78.71 |
|
Cost of Revenue
|
1.59 | 631.91 | 2,207.90 | 0.30 | 77.86 |
|
Gross Profit
|
-1.59 | 8.40 | 875.90 | 31.92 | 0.84 |
|
Operating Expenses
|
1.59 | 884.89 | 736.30 | 162.14 | 107.16 |
|
Operating Profit (EBIT)
|
-1.59 | -244.57 | 139.60 | -129.92 | -106.31 |
|
Other Income
|
-- | -- | 0.00 | 0.86 | 0.76 |
|
Profit before Tax
|
-0.37 | -2,163.41 | 5.40 | -131.76 | 7.97 |
|
Provision for Tax
|
0.21 | 15.76 | 14.30 | -- | -114.28 |
|
Profit after Tax (Net Income)
|
-0.58 | -2,146.32 | -0.30 | -131.76 | 7.97 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 47.31 | -0.34 | -131.76 | 10.20 |
Liabilities ($ Mln)
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
86.32 | -409.35 | -780.40 | 286.12 | 138.80 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
3.02 | 1,030.24 | 2,739.20 | 76.52 | 38.22 |
|
Current Liabilities
|
0.78 | 186.79 | 2,108.80 | 63.02 | 46.05 |
|
Total Liabilities
|
90.12 | 807.69 | 4,412.70 | 425.65 | 223.06 |
Assets ($ Mln)
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
89.20 | 722.58 | 3,260.70 | 156.48 | 51.54 |
|
Current Assets
|
0.92 | 85.10 | 1,152.00 | 269.18 | 171.52 |
|
Total Assets
|
90.12 | 807.69 | 4,412.70 | 425.65 | 223.06 |
|
Total Debt*
|
-- | 818.81 | 3,183.70 | 23.64 | 22.85 |
|
Net Current Assets
|
0.14 | -101.69 | -956.80 | 206.16 | 125.47 |
Cashflow ($ Mln)
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.19 | 205.19 | 346.10 | -75.62 | -123.96 |
|
Cash Flow from Investing Activities
|
-- | -423.84 | 31.30 | 92.22 | -53.02 |
|
Cash from Financing Activities
|
89.90 | 306.15 | -394.50 | 1.08 | 1.34 |
|
Net Cash Inflow / Outflow
|
-- | -- | 1.42 | 17.68 | 1.13 |
Ratios
Profitability Ratios
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-1.35 | -621.90 | -0.01 | -34.71 | 5.47 |
|
ROE (%)
|
-1.35 | 3,339.12 | 0.06 | -39.23 | 6.40 |
|
ROA (%)
|
-1.28 | -371.96 | -0.01 | -27.90 | 3.03 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -335.20 | -0.01 | -398.26 | 10.13 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 0.18 | 0.14 | -0.50 | 1.87 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-6,757.58 | -4,636.52 | -102.70 | -138.01 | 107.44 |
|
EPS Growth (%)
|
-84.67 | -31.35 | -1.00 | -1.24 | 1.01 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-149.65 | -0.21 | -5,142.26 | -19.34 | 254.87 |
|
Price / Book Value
|
1.01 | -1.12 | -1.98 | 8.91 | 14.63 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 70.38 | 2.46 | -17.58 | -19.54 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 2.92 | -4.08 | 0.08 | 0.16 |
|
Short term debt to equity ratio
|
-- | 0.37 | -1.24 | 0.07 | 0.04 |
|
Current Ratio
|
1.18 | 0.46 | 0.55 | 4.27 | 3.72 |
|
Quick Ratio
|
-- | -- | 0.53 | 4.26 | 2.18 |
|
Interest Coverage
|
-1,299.75 | -2.53 | 1.03 | -49.89 | -285.78 |
Operating Efficiency Ratios
| Viscogliosi Brothers Acquisition (VBOCU) | Core Scientific Inc (CORZ) | Lionheart III Corp (LION) | ChemoCentryx (CCXI) | Velocitycquisition Corp. Class A (VELO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 0.04 | 28.46 | 1.28 | 18.53 |
|
Asset Turnover
|
0.00 | 1.11 | 0.71 | 0.07 | 0.30 |
|
Receivable days
|
-- | 0.55 | 93.08 | 3.29 | 64.13 |
|
Inventory Days
|
-- | -- | 2.27 | 1,029.23 | 219.73 |
|
Payable days
|
-- | 15.58 | 37.06 | 11,865.18 | 51.81 |
|
Cash Conversion Cycle
|
-- | -- | 58.29 | -10,832.66 | 232.05 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
